Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation

Published:2011-06 Issue:6 Volume:17 Page:901-907
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Coppoletta Stefania,Tedone Elisabetta,Galano Barbara,Soracco Monica,Raiola Anna Maria,Lamparelli Teresa,Gualandi Francesca,Bregante Stefania,Ibatici Adalberto,di Grazia Carmen,Dominietto Alida,Varaldo Riccardo,Bruno Barbara,Frassoni Francesco,Van Lint MariaTeresa,Bacigalupo Andrea

Funder

Fondazione CARIGE, Genova, Associazione Italiana Ricerca Contro il Cancro, Milano, and Fondazione Ricerca Trapianto Midollo Osseo, Genova

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference27 articles.

1. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT;van Esser;Blood,2001

2. EBV reactivation and post-transplant lymphoproliferative disorders following allogeneic SCT;Ocheni;Bone Marrow Transplant,2008

3. Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients;Aalto;Clin Infect Dis,2007

4. High incidence of PTLD after non-T cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment;Juvonen;Bone Marrow Transplant,2003

5. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral monitoring in immunocompromised hosts;Molecular Medical Microbiology;2024

2. Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?;Bone Marrow Transplantation;2023-11-25

3. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07

4. Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia;Transplantation and Cellular Therapy;2023-08

5. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative;Frontiers in Immunology;2023-03-09